3-[1-[2-[4-[[6-Hydroxy-2-(4-oxocyclohexa-1,5-dien-1-yl)-1-benzothiophen-3-yl]oxy]phenoxy]ethyl]piperidin-4-yl]propyl nitrate

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-[1-[2-[4-[[6-Hydroxy-2-(4-oxocyclohexa-1,5-dien-1-yl)-1-benzothiophen-3-yl]oxy]phenoxy]ethyl]piperidin-4-yl]propyl nitrate
• 英文别名: 3-[1-[2-[4-[[6-hydroxy-2-(4-oxocyclohexa-1,5-dien-1-yl)-1-benzothiophen-3-yl]oxy]phenoxy]ethyl]piperidin-4-yl]propyl nitrate
• 化学式: C30H32N2O7S
• 分子量: 564.7
• InChiKey: DLQYBRWMXJMCLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  40
• 可旋转键数：
  11
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  142
• 氢给体数：
  1
• 氢受体数：
  9

文献信息

• COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS
  申请人：The Board of Trustees of the University of Illinois

  公开号：EP2912033A1

  公开（公告）日：2015-09-02
• [EN] COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS<br/>[FR] COMPOSITIONS ET PROCÉDÉS PERMETTANT DE TRAITER DES AFFECTIONS MÉDICALES ASSOCIÉES AUX ŒSTROGÈNES
  申请人：UNIV ILLINOIS

  公开号：WO2014066695A1

  公开（公告）日：2014-05-01

  Disclosed is a compound of formula (I). or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions including the compound of formula (I) and methods of using the compound of formula (I).